Photo by nci from unsplash
Immune checkpoint inhibitors (ICI) leverage immune system to target cancer cells. In basic research, these checkpoints are key regulators of atherosclerosis. There are no clinical data testing whether ICI accelerate… Click to show full abstract
Immune checkpoint inhibitors (ICI) leverage immune system to target cancer cells. In basic research, these checkpoints are key regulators of atherosclerosis. There are no clinical data testing whether ICI accelerate atherosclerosis. We included 51 consecutive patients treated with an ICI for
Keywords:
immune checkpoint;
checkpoint inhibitors;
patients treated;
aortic plaque;
plaque progression
Journal Title: Journal of the American College of Cardiology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!